Archive for February, 2009
« Previous EntriesZoloft, Lexapro Are Significantly Better Than Other Antidepressants
Thursday, February 26th, 2009New research published online Jan. 29 in the journal The Lancet concluded that Pfizer Inc’s sertraline (Zoloft) and Forest Laboratories Inc’s escitalopram (Lexapro) are the most effective and well-tolerated antidepressants among a group of 12 new drugs.
The findings were based on a review of 17 studies consisting of almost 26,000 patients with depression between 1991 […]
Allergy Season Has Officially Begun
Wednesday, February 25th, 2009Allergy Season Has Officially Begun
Many of us are enjoying the nice weather outside, but we’re not enjoying what else it brings: allergies. The season of coughing, itchy eyes and sneezing has officially begun.
“I’m allergic to all trees and grasses,” said Thomas Wells as he waits to get an allergy shot.
“It affects me a bit. You […]
Peripheral Artery Disease
Tuesday, February 17th, 2009Approximately 1.5 million people live in 17,000 nursing homes within the United States. Ninety percent are 65 years or older and 24 percent are 85 years or older. It is estimated that by 2030, more than 8 million seniors will reside in nursing homes or long-term care facilities. Reports show that with the advance in […]
THERE GOES RETIREMENT
Sunday, February 15th, 2009THERE GOES RETIREMENT
With their finances in shambles, many in the 60-plus crowd are looking for jobs. Here’s how some are finding work — and adjusting to new lives.
By KELLY GREENE
Wall St Journal
Feb 14, 2009
The advice in recent months — from financial planners, economists and educators — has been unvarying: Retirees whose nest eggs have cracked […]
Rosiglitazone improves fat loss and insulin resistance in people with lipoatrophy
Thursday, February 12th, 2009The diabetes drug rosiglitazone (Avandia) improved limb lipoatrophy in HIV-positive people taking antiretroviral therapy, researchers reported Wednesday at the Sixteenth Conference on Retroviruses and Opportunistic Infections in Montréal. However the researchers did not study the drug’s effect on facial fat loss.
Many people with HIV develop peripheral lipoatrophy, or fat loss in the face, limbs […]
